This information is current as Cell Depletion In Vivo BObinutuzumab and Significantly Augments Function Mediated by Rituximab or Minimally Interferes with Immune Effector-Selective Inhibitor Idelalisib δ The PI 3

semanticscholar(2018)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要